Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 CAD | -2.94% | -2.94% | -50.75% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
William Rice
CEO | Chief Executive Officer | 65 | 28/13/28 |
C. Payne
DFI | Director of Finance/CFO | 61 | 27/22/27 |
Chief Tech/Sci/R&D Officer | - | 01/19/01 | |
Rafael Bejar
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/20/01 |
Investor Relations Contact | - | - | |
Marc Wiles
LAW | General Counsel | - | - |
Brooks Ensign
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Burger
BRD | Director/Board Member | 80 | 19/07/19 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 13/22/13 |
Mark Vincent
BRD | Director/Board Member | 71 | 19/07/19 |
Director/Board Member | 74 | 15/14/15 | |
William Rice
CEO | Chief Executive Officer | 65 | 28/13/28 |
Warren Whitehead
BRD | Director/Board Member | 71 | 07/11/07 |
Carol Ashe
BRD | Director/Board Member | 66 | 15/18/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,717,701 | 12,619,162 ( 80.29 %) | 0 | 80.29 % |
Company contact information
Aptose Biosciences, Inc.
251 Consumers Road Suite 1105
M2J 4R3, Toronto
+647 479 9828
http://www.aptose.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.75% | 19M | |
+1.77% | 42.86B | |
+47.70% | 41.36B | |
+12.24% | 42.74B | |
-8.83% | 27.68B | |
+7.44% | 25.15B | |
-23.01% | 18.63B | |
+30.56% | 12.37B | |
-1.82% | 11.92B | |
+8.35% | 11.21B |
- Stock Market
- Equities
- APS Stock
- Company Aptose Biosciences Inc.